Latest News for: jpm
Edit
ICU JPM Monitoring Progress Of 500 Projects, Involving Over RM27 Billion, In Kelantan
Malaysian National News Agency 17 Jan 2026
Edit
Independent Record
16 Jan 2026
Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs
Independent Record
16 Jan 2026
SHANGHAI and HONG KONG, Jan.
Edit
The Galveston Daily News
16 Jan 2026
Henlius Showcases "Globalisation 2.0" Strategy and Mid-to-Long-Term Innovation Blueprint at JPM 2026
The Galveston Daily News
16 Jan 2026
SAN FRANCISCO, Jan.
Edit
Independent Record
16 Jan 2026
Kelun-Biotech Showcases Innovative Achievements and Future Development Strategy at the 44th Annual JPM Healthcare Conference
Independent Record
16 Jan 2026
Edit
Lodi News Sentinel
15 Jan 2026
JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth
Lodi News Sentinel
15 Jan 2026
clientsComplex modalities are WuXi Biologics' core growth ....
Edit
Investor Presentation ALX presentation at JPM 2026 12Jan2026 FINAL (698186) (ALX Oncology Holdings Inc)
Public Technologies 15 Jan 2026
). NASDAQ GS. JP Morgan Healthcare Conference January 2026. ALXO. © ALX Oncology Inc. All rights reserved. ALX is Rapidly Advancing Novel Cancer Treatments. Leading CD47 program in development with potential to be next targeted immuno-oncology breakthrough.
Edit
Final Liquidia JPM 20260114 1600 (Liquidia Corporation)
Public Technologies 15 Jan 2026
) Corporate Overview. J.P. Morgan Healthcare Conference 2026. January 14, 2026. ©2026 LIQUIDIA CORPORATION ALL RIGHTS RESERVED. Shaping the Future of Care in Pulmonary and Vascular Disease ... Improving inhaled drug delivery ... Focusing on prostacyclin class ... 4.
Edit
Corporate Presentation (TuHURA Corporate Deck JPM 2026 FINAL) (Tuhura Biosciences Inc)
Public Technologies 15 Jan 2026
) Overcoming Resistance to Cancer Immunotherapy. January 2026. tuhurabio.com. We are a Phase 3 immuno-oncology company developing three distinct novel technologies and therapeutics to overcome primary and acquired resistance to cancer immunotherapies ... 4.
Edit
GEHC JPM 2026 Slides FINAL (GE HealthCare Technologies Inc)
Public Technologies 15 Jan 2026
) 44th Annual J.P. Morgan Healthcare Conference. January 13, 2026. © 2026 GE HealthCare. GE is a trademark of General Electric Company used under trademark license. Strategic framework. Purpose.. Why we exist. Create a world where healthcare has no limits.
Edit
2026 JPM Presentation - WuXi AppTec 20260114 (WuXi AppTec Co Ltd)
Public Technologies 15 Jan 2026
) WuXi AppTec. 2026 J.P. Morgan Healthcare Conference. January 14, 2026. 25 Years of Consistent Dedication. With Customers as Our Top Priority, Committed to Enabling Innovation and Bringing Breakthrough Treatments to Patients Worldwide. Our Vision ... Cost. 3.
Edit
Final Trade: MLCO, JPM, TMUS, FCX
CNBC 14 Jan 2026
The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders ... .
Edit
Montana Standard
14 Jan 2026
Former Drawbridge Health CEO Launches Manifold Health AI at JPM to Build the First Digital ...
Montana Standard
14 Jan 2026
13, 2026 /PRNewswire/ -- Manifold Health AI today ...
Edit
Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference
CNBC 14 Jan 2026
Novo Nordisk's CEO spoke about GLP-1 pricing and Pfizer's CEO spoke about the company's obesity ambitions while at the JPMorgan Healthcare Conference ... .
Edit
XRAY 2026 JPM Healthcare Conference Presentation (Dentsply Sirona Inc)
Public Technologies 14 Jan 2026
). J.P. Morgan Healthcare Conference. Dan Scavilla. President and Chief Executive Officer. January 13, 2026. Dentsply Sirona Overview. Agenda. 5. The Markets We Compete In. Product Portfolio and Connected Dentistry ... Dentsply Sirona ... Key Statistics. 100+ ... 400k+.
- 1
- 2
- Next page »